https://www.selleckchem.com/products/ag-270.html
The economic burden of diabetes from a societal perspective is well documented in the cost-of-illness literature. However, the effect of considering social costs in the results and conclusions of economic evaluations of diabetes-related interventions remains unknown. To investigate whether the inclusion of social costs (productivity losses and/or informal care) might change the results and conclusions of economic evaluations of diabetes-related interventions. A systematic review was designed and launched on Medline and the Cost-Effective
Мне нравится
Комментарий
Перепост
